Spray Dried Smectite Clay Particles as a Novel Treatment against Obesity

Pharm Res. 2018 Dec 5;36(1):21. doi: 10.1007/s11095-018-2552-9.

Abstract

Purpose: To explore the feasibility of spray dried smectite clay particles fabricated from montmorillonite or laponite materials for adsorbing dietary lipids and reducing rodent weight gain in vivo.

Methods: Spray dried montmorillonite (SD-MMT) and spray dried laponite (SD-LAP) particles were prepared via spray drying. Particle morphology, surface area and redispersion/aggregation properties in aqueous media were characterized. The ability of SD-MMT and SD-LAP particles to inhibit lipid digestion kinetics and adsorb lipid species from solution was assessed during in vitro lipolysis using proton nuclear magnetic resonance analysis. SD-MMT and SD-LAP particles were dosed to rodents fed a high-fat diet and their effect on body weight gain was evaluated.

Results: Both SD-MMT and SD-LAP particles adsorbed significant quantities of medium chain triglycerides and lipolytic products from solution during in vitro lipolysis. At a concentration of 50% w/w relative to lipid content, SD-MMT and SD-LAP particles adsorbed 42% and 94% of all lipid species, respectively. SD-MMT and SD-LAP particles also reduced the extent of rodent weight gain relative to the negative control treatment group and performed similarly to orlistat via an alternate mechanism of action.

Conclusions: Spray dried smectite clay particles (SD-MMT and SD-LAP) with significant adsorptive capacities for dietary lipids and digestion products were successfully fabricated. These particles may be developed as novel anti-obesity treatments with fewer adverse effects than currently marketed treatment options.

Keywords: digestion; laponite; lipid; montmorillonite; obesity.

MeSH terms

  • Adsorption / drug effects
  • Animals
  • Bentonite / chemistry
  • Bentonite / pharmacokinetics
  • Bentonite / pharmacology*
  • Body Weight / drug effects
  • Lipase / metabolism
  • Lipid Metabolism / drug effects
  • Lipolysis / drug effects
  • Male
  • Nanoparticles / therapeutic use
  • Obesity / drug therapy*
  • Obesity / metabolism
  • Particle Size
  • Rats
  • Rats, Sprague-Dawley
  • Silicates / chemistry
  • Silicates / pharmacokinetics
  • Silicates / pharmacology*
  • Triglycerides / metabolism

Substances

  • Silicates
  • Triglycerides
  • Bentonite
  • Smectite
  • laponite
  • Lipase